Карта сайта Интеллектуальная поисковая система
Добавить свою ссылку по ключевому запросуПоисковая система v3.kz поможет ускорить индексацию вашего сайта выводит в Топ
|
Карта сайта Интеллектуальная поисковая системаДобавить свою ссылку по ключевому запросуПоисковая система v3.kz поможет ускорить индексацию вашего сайта выводит в Топ |
|
|
The differentiation syndrome (previously called "retinoic acid syndrome") is a potentially fatal complication of induction chemotherapy in patients with acute promyelocytic leukemia (APL). Retinoic acid syndrome (RAS) is a potentially life-threatening complication observed in patients with acute promyelocytic leukemia (APML) and first thought to be specifically associated with all-trans retinoic acid (ATRA) (also known as tretinoin) treatment. The modern study in syndrome differentiation of the chronic obstructive pulmonary disease. Differentiation syndrome (DS) is a life- threatening complication that may occur during the treatment of acute promyelocytic leukemia (APL) by all trans-retinoic acid (ATRA) therapy. Differentiation syndrome (leukocyte activation syndrome, APL differentiation syndrome) is characterised by: Web Resources for Differentiation syndrome. Relevant Clinical Literature. Pubmed on Differentiation syndrome. RCT with Differentiation syndrome. 1. What statement in differentiation of syndromes is not true for TCM The differentiation syndrome (also know as retinoic acid syndrome and ATRA syndrome) is a cytokine release syndrome that is seen in ~1/4 of patients after induction chemotherapy with ATRA or... Differentiation syndrome (DS), formerly known as retinoic acid syndrome, is a relatively common and potentially severe complication seen in patients with acute promyelocytic leukemia treated with... retinoic acid syndrome. (redirected from APL differentiation syndrome) Also found in: Wikipedia. Synonyms: Diffrentiation Syndrome, Retinoic Acid Syndrome, ATRA Syndrome. Информация взята v3.kz |
|
|
|
загрузка...
|